XML 40 R20.htm IDEA: XBRL DOCUMENT v3.19.3
STOCKHOLDERS' EQUITY Share-Based Compensation (Notes)
9 Months Ended
Sep. 30, 2019
STOCKHOLDERS' EQUITY STOCKHOLDERS’ EQUITY

Stock-Based Compensation

Information with respect to option shares granted under all of our stock incentive plans for the nine months ended September 30, 2019 was as follows:
 
Time-Based Shares
Performance-Based Shares
Total Shares
Weighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Options outstanding at January 1, 2019
891,892


891,892

$8.46
 
 
Granted



$—
 
 
Exercised
(66,506
)

(66,506
)
$7.39
 
 
Forfeited or canceled
(231,886
)

(231,886
)
$10.96
 
 
Options outstanding at September 30, 2019
593,500


593,500

$7.60
1.37
$—
Options vested at September 30, 2019 or expected to vest
 
 
593,500

$7.60
1.37
$—
Options exercisable at September 30, 2019
 
 
593,500

$7.60
1.37
$—


Information with respect to our non-vested restricted stock units for the nine months ended September 30, 2019 was as follows:
 
Non-Vested Restricted Stock Units
 
Time-Based Shares
Performance-Based Shares
Total Shares
Weighted-
Average
Grant-Date
Fair Value
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Non-vested at January 1, 2019
1,978,676

966,143

2,944,819

$4.91
 
 
Granted
1,212,076

411,043

1,623,119

$7.33
 
 
Vested
(830,949
)
(666,451
)
(1,497,400
)
$4.85
 
 
Forfeited
(214,710
)
(156,470
)
(371,180
)
$5.39
 
 
Non-vested at September 30, 2019
2,145,093

554,265

2,699,358

$6.33
1.12
$16,682
Expected to vest
 
 
2,699,358

$6.33
1.12
$16,682


Stock-based compensation was included in the following captions in our condensed consolidated statements of operations for the three and nine months ended September 30, 2019 and 2018 (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2019

2018
 
2019
 
2018
Cost of products revenues
$
103

 
$
40

 
$
244

 
$
83

Cost of services revenues
82

 
55

 
177

 
139

Research and development expenses
305

 
236

 
762

 
439

Marketing and selling expenses
532

 
419

 
1,276

 
1,152

General and administrative expenses
1,023

 
1,326

 
3,329

 
2,518

 
$
2,045

 
$
2,076

 
$
5,788

 
$
4,331